|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanaka K, Ichikawa Y and Endo I: Liver
resection for advanced or aggressive colorectal cancer metastases
in the era of effective chemotherapy: A review. Int J Clin Oncol.
16:452–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Rosa M, Pace U, Rega D, Costabile V,
Duraturo F, Izzo P and Delrio P: Genetics, diagnosis and management
of colorectal cancer (Review). Oncol Rep. 34:1087–1096.
2015.PubMed/NCBI
|
|
4
|
Yoshino T, Muro K, Yamaguchi K, Nishina T,
Denda T, Kudo T, Okamoto W, Taniguchi H, Akagi K, Kajiwara T, et
al: Clinical validation of a multiplex kit for ras mutations in
colorectal cancer: Results of the RASKET (RAS KEy Testing)
Prospective, multicenter study. EBioMedicine. 2:317–323. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bringuier PP, Umbas R, Schaafsma HE,
Karthaus HF, Debruyne FM and Schalken JA: Decreased E-cadherin
immunoreactivity correlates with poor survival in patients with
bladder tumors. Cancer Res. 53:3241–3245. 1993.PubMed/NCBI
|
|
7
|
Krishnadath KK, Tilanus HW, van
Blankenstein M, Hop WC, Kremers ED, Dinjens WN and Bosman FT:
Reduced expression of the cadherin-catenin complex in oesophageal
adenocarcinoma correlates with poor prognosis. J Pathology.
182:331–338. 1997. View Article : Google Scholar
|
|
8
|
Pena C, Garcia JM, Silva J, García V,
Rodríguez R, Alonso I, Millán I, Salas C, De Herreros AG, Muñoz A
and Bonilla F: E-cadherin and vitamin D receptor regulation by
SNAIL and ZEB1 in colon cancer: Clinicopathological correlations.
Hum Mol Genet. 14:3361–3370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanazawa T, Watanabe T, Kazama S, Tada T,
Koketsu S and Nagawa H: Poorly differentiated adenocarcinoma and
mucinous carcinoma of the colon and rectum show higher rates of
loss of heterozygosity and loss of E-cadherin expression due to
methylation of promoter region. Int J Cancer. 102:225–229. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Wang Z, Chen M, Peng L, Wang X,
Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell
invasion and migration in colorectal cancer. Mol Cancer. 11:232012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lei SL, Zhao H, Yao HL, Chen Y, Lei ZD,
Liu KJ and Yang Q: Regulatory roles of microRNA-708 and microRNA-31
in proliferation, apoptosis and invasion of colorectal cancer
cells. Oncol Lett. 8:1768–1774. 2014.PubMed/NCBI
|
|
14
|
Liu L, Chen L, Xu Y, Li R and Du X:
microRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arndt GM, Dossey L, Cullen LM, Lai A,
Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, et al:
Characterization of global microRNA expression reveals oncogenic
potential of miR-145 in metastatic colorectal cancer. BMC Cancer.
9:3742009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Krijger I, Mekenkamp LJ, Punt CJ and
Nagtegaal ID: MicroRNAs in colorectal cancer metastasis. J
Pathology. 224:438–447. 2011. View Article : Google Scholar
|
|
17
|
Liu X, Duan B, Dong Y, He C, Zhou H, Sheng
H, Gao H and Zhang X: MicroRNA-139-3p indicates a poor prognosis of
colon cancer. Int J Clin Exp Pathol. 7:8046–8052. 2014.PubMed/NCBI
|
|
18
|
Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H
and Yu H: Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p
expression in colon cancer. Am J Transl Res. 6:391–401.
2014.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krakhmal NV, Zavyalova MV, Denisov EV,
Vtorushin SV and Perelmuter VM: Cancer Invasion: Patterns and
Mechanisms. Acta Naturae. 7:17–28. 2015.PubMed/NCBI
|
|
22
|
Kim SA, Lee EK and Kuh HJ: Co-culture of
3D tumor spheroids with fibroblasts as a model for
epithelial-mesenchymal transition in vitro. Exp Cell Res.
335:187–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dass SD, Cheah PL, Ong DB, Teoh KH and
Looi LM: E-cadherin downregulation at the infiltrating tumour front
is associated with histological grade and stage in colorectal
carcinoma of Malaysians. Malay J Pathol. 37:19–24. 2015.
|
|
24
|
Bruun J, Kolberg M, Nesland JM, Svindland
A, Nesbakken A and Lothe RA: Prognostic significance of β-Catenin,
E-Cadherin and SOX9 in Colorectal Cancer: Results from a large
population-representative series. Front Oncol. 4:1182014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nielsen BS, Jørgensen S, Fog JU, Søkilde
R, Christensen IJ, Hansen U, Brünner N, Baker A, Møller S and
Nielsen HJ: High levels of microRNA-21 in the stroma of colorectal
cancers predict short disease-free survival in stage II colon
cancer patients. Clin Exp Metastasis. 28:27–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Diaz R, Silva J, Garcia JM, Lorenzo Y,
García V, Peña C, Rodríguez R, Muñoz C, García F, Bonilla F and
Domínguez G: Deregulated expression of miR-106a predicts survival
in human colon cancer patients. Genes Chromosomes Cancer.
47:794–802. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Korpal M and Kang Y: The emerging role of
miR-200 family of microRNAs in epithelial-mesenchymal transition
and cancer metastasis. RNA Biol. 5:115–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen
L, Chen H and Liu J: miR-200c inhibits invasion, migration and
proliferation of bladder cancer cells through down-regulation of
BMI-1 and E2F3. J Transl Med. 12:3052014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and -5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
